These developments have turned the spotlight on less-invasive treatment patterns, which, along with advances in plating and nailing systems, are facilitating the therapy of complicated fractures.
New analysis from Frost & Sullivan (medicaldevices.frost.com), U.S. Trauma Fixation Devices Markets, finds that the market earned revenues of $2.20 billion in 2007 and estimates this to reach $4.70 billion in 2014.
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the U.S. Trauma Fixation Devices Markets, please send an email to Stacie Kopecki, Corporate Communications, at skopecki_pr[.]frost.com, with the following information: your full name, company name, title, telephone number, company email address, company website, city, state and country. We will send an overview to you via email upon receipt of the above information. All media inquiries please reply directly to stacie.kopecki[.]frost.com
Growth factor products and image-guided techniques expect usage in trauma fixation for complex cases to rise over the next three to five years and could become ubiquitous in the long term. As part of these proactive product development efforts, manufacturers of trauma fixation instruments are collaborating with surgeons to aid in the crucial steps of the development process.
Companies have invested substantial effort, time, and resources in making this alliance successful, and have followed up their initial endeavors with the provision of practical training and support to the surgeons. This will create loyalty among the surgeons and encourage them to promote instrumented procedures, which have already seen their emergence as the preferred alternative in orthopedics during the last three decades.
"The much improved, minimally invasive fixation implants have enabled smoother and quicker rehabilitation periods," says Frost & Sullivan Industry Analyst Aarti Shetty. "Antibiotic prophylaxis has lowered the infection risk associated with surgery, while instrumented procedures have reduced instances of malunions and inflexibility."
Although, there are many concerns, in which trying to replicate the external fixation devices market's business model in the trauma market needs alleviating.
"The availability of sophisticated drugs that improve bone density and lower the risk of fracture by strengthening the bone has driven down the scope of the trauma fixation market," remarks Shetty. "The resulting loss of revenue and the constant development of superior drugs for treatment of bone density-related conditions will further hamper the trauma fixation market."
The external fixation market is experiencing a golden period, with the market having grown from $3.92 million to $5.80 million between 2004 and 2008.
"Moreover, the stainless steel rods that are commonly used in older systems have been replaced with carbon fiber rods, which are lighter but do not lend themselves to easy sterilization," observes Shetty. "This, combined with their extensive recognition in the trauma market, has boosted the sales of new assemblies at a steady pace."
U.S. Trauma Fixation Devices Markets is part of the Medical Devices Growth Partnership Service program, which also includes research in the following markets: Cardiovascular, Orthopedics, Wound Care, and Surgical Equipment. All research services included in subscriptions provide detailed market opportunities and pre-evaluated industry trends that all follow extensive interviews with market participants. Interviews with the press are available.
Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's Team Research, Growth Consulting and Growth Team Membership™ empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.
U.S. Trauma Fixation Devices Markets - N1AB